Anavex Life Sciences Corp.: Form 8-K, filed Jul 28, 2025
Filed with the SEC on Jul 28, 2025 and accepted by EDGAR at Jul 25, 2025, 23:26 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001731122-25-001033. Last ingested by Listed: Oct 24, 2026, 15:11 ET. Listed shows no prices and gives no investment advice.